Hypertrophic cardiomyopathy: From mutation to functional analysis of defective protein

Croatian Medical Journal

Volumn 52, Issue 3, 2011, Pages 384-391

  Capek, Pavel ^a   Vondrasek, Jiri ^b   Skvor, Jiri ^a   Brdicka, Radim ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MYOSIN; MYOSIN 7; UNCLASSIFIED DRUG;

ARTICLE; COMPUTER MODEL; CZECH REPUBLIC; DNA DETERMINATION; EXON; GENE MUTATION; HUMAN; HYDROPHOBICITY; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MOLECULAR MODEL; MUTATION; PROTEIN ANALYSIS; PROTEIN DEFECT; PROTEIN INTERACTION; PROTEIN STRUCTURE;

ADULT; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; COMPUTER SIMULATION; CZECH REPUBLIC; DATABASES, GENETIC; DNA; HUMANS; MALE; MODELS, MOLECULAR; MUTATION; MYOSINS; RISK ASSESSMENT; YOUNG ADULT;

EID: 80051934916     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2011.52.384     Document Type: Article

References (38)

1. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O'Connell J, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force. The definition and classification of cardiomyopathies. Circulation. 1996;93:841-2.
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: echocardiographic analysis of 4111 subjects in the CARDIA study. Circulation. 1995;92:785-9.
3. Watkins H, Ashrafian H, McKenna WJ. The genetics of hypertrophic cardiomyopathy: Teare redux. Heart. 2008;94:1264-8.
4. Stroumpoulis KI, Pantazopoulos IN, Xanthos TT. Hypertrophic cardiomyopathy and sudden cardiac death. World J Cardiol. 2010;2:289-98.
5. Perrot A, Schmidt-Traub H, Hoffmann B, Prager M, Bit-Avragim N, Rudenko RI, et al. Prevalence of cardiac beta-myosin heavy chain gene mutations in patients with hypertrophic cardiomyopathy. J Mol Med. 2005;83:468-77.
6. Davies MJ, McKenna WJ. Hypertrophic cardiomyopathy - pathology and pathogenesis. Histopathology. 1995;26:493-500.
7. McKenna W, Deanfield J, Farugui A, England D, Oakley C, Goodwin J. Prognosis in hypertrophic cardiomyopathy: role of age and clinical electrocardiographic and hemodynamic features. Am J Cardiol. 1981;47:532-8.
8. Davidson SJ, Turner N, Tillyer L. Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency. Blood Coagul Fibrinolysis. 2010;21:707-8.
9. Svobodova H, Stulc T, Kasalova Z, Dolezalova R, Marinov I, Capek P, et al. The effect of rosiglitazone on the expression of thrombogenic markers on leukocytes in type 2 diabetes mellitus. Physiol Res. 2009;58:701-7.
10. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res. 2008;77:659-66.
11. Fatkin D, Graham RM. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev. 2002;82:945-80.
12. Fung DC, Yu B, Littlejohn T, Trent RJ. An online locus-specific mutation database for familial hypertrophic cardiomyopathy. Hum Mutat. 1999;14:326-32.
13. Capek P, Skvor J. Hypertrophic cardiomyopathy: Molecular genetic analysis of exons 9 and 11 of the TNT2 gene in Czech patiens. Methods Inf Med. 2006;45:169-72.
14. Millat G, Bouvagnet P, Chevalier P, Dauphin C, Jouk PS, Da Costa A, et al. Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet. 2010;53:261-7.
15. Brouwer WP, Van Dijk SJ, Stienen GJ, Van Rossum AC, Van der Velden J, Germans T. The development of familial hypertrophic cardiomyopathy: from mutation to bedside. Eur J Clin Invest. 2011;41:568-78.
16. Geisterfer-Lowrance AA, Kass S, Tanigawa G, Vosberg HP, McKenna W, Seidman CE. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990;62:999-1006.
17. Buvoli M, Hamady M, Leinwand LA, Knight R. Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med. 2008;18:141-9.
18. Walsh R, Rutland C, Thomas R, Loughna S. Cardiomyopathy: a systematic review of disease-causing mutations in myosin heavy chain 7 and their phenotypic manifestations. Cardiology. 2010;115:49-60.
19. Arad M, Penas-Lado M, Monserrat L, Maron BJ, Sherrid M, Ho CY, et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005;112:2805-11.
20. Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 1992;326:1108-14.
21. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 2008;117:2893-901.
22. Karam S, Raboisson MJ, Ducreux C, Chalabreysse L, Milost G, Bozio A, et al. A de novo mutation of the beta cardiac myosin heavy chain gene in an infantile restrictive cardiomyopathy. Congenit Heart Dis. 2008;3:138-43.
23. Maupetit J, Derreumaux P, Tuffery P. PEP-FOLD: an online resource for de novo peptide structure prediction. Nucleic Acids Res. 2009;37:W498-503.
24. Capek PC. Gene symbol: MYH7. Disease: cardiomyopathy, hypertrophic. Hum Genet. 2005;118:537.
25. Wang S, Zou Y, Fu C, Xu X, Wang J, Song L, et al. Worse prognosis with gene mutations of beta-myosin heavy chain than myosinbinding protein C in Chinese patients with hypertrophic cardiomyopathy. Clin Cardiol. 2008;31:114-8.
26. Woo A, Rakowski H, Liew JC, Zhao MS, Liew CC, Parker TG, et al. Mutations of the beta myosin heavy chain gene in hypertrophic cardiomyopathy: critical functional sites determine prognosis. Heart. 2003;89:1179-85.
27. Van Driest SL, Ackerman MJ, Ommen SR, Shakur R, Will ML, Nishimura RA, et al. Prevalence and severity of benign mutations in the β-myosin heavy chain, cardiac troponin T, and α-tropomyosin genes in hypertrophic cardiomyopathy. Circulation. 2002;106:3085-90.
28. Zheng DD, Yang JH, Tao Q, Geng M, Lin J, Yang XJ, et al. Mutations in the beta-myosin heavy chain gene in southern Chinese families with hypertrophic cardiomyopathy. J Int Med Res. 2010;38:810-20.
29. Roncarati R, Latronico MV, Musumeci B, Aurino S, Torella A, Bang ML, et al. Unexpectedly low mutation rates in beta-myosin heavy chain and cardiac myosin binding protein genes in Italian patients with hypertrophic cardiomyopathy. J Cell Physiol. 2011 [Epub ahead of print].
30. Miroshnichenko NS, Balanuk IV, Nozdrenko DN. Packing of myosin molecules in muscle thick filaments. Cell Biol Int. 2000;24:327-33.
31. Rayment I, Holden HM, Sellers JR, Fananapazir L, Epstein ND. Structural interpretation of the mutations in the beta-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy. 1995;25:3864-8.
32. Cuda G, Fananapazir L, Epstein ND, Sellers JR. The in vitro motility activity of β-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. J Muscle Res Cell Motil. 1997;18:275-83.
33. Nishi H, Kimura A, Harada H, Koga Y, Adachi K, Matsuyama K, et al. A myosin missense mutation, not a null allele, causes familial hypertrophic cardiomyopathy. Circulation. 1995;91:2911-5.
34. Van Driest SL, Jaeger MA, Ommen SR, Will ML, Gersh BJ, Tajik AJ, et al. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44:602-10.
35. Redwood CS, Moolman-Smook JC, Watkins H. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. Cardiovasc Res. 1999;44:20-36.
36. Harada H, Kimura A, Nishi H, Sasazuki T, Toshima H. A missense mutation of cardiac beta-myosin heavy chain gene linked to familial hypertrophic cardiomyopathy in affected Japanese families. Biochem Biophys Res Commun. 1993;194:791-8.
37. Andersen PS, Havndrup O, Bundgaard H, Moolman-Smook JC, Larsen LA, Mogensen J, et al. Myosin light chain mutations in familial hypertrophic cardiomyopathy: phenotypic presentation and frequency in Danish and South African populations. J Med Genet. 2001;38:E43.
38. Ng PC, Henikoff S. Predicting the effects of amino acid substitutions on protein function. Annu Rev Genomics Hum Genet. 2006;7:61-80.